GSK’s Aspen sale is SA’s biggest block

Pharmaceuticals firm GlaxoSmithKline disposed of a third of its stake in Aspen, a South African company, on Tuesday night, raising $700m through a block that was well supported before launch by wall-crossed accounts. It was South Africa’s largest ever block trade.